Observational studyIn vivo (Athens, Greece)

Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years.

Mioko Matsuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.